From linkage studies to epigenetics: What we know and what we need to know in the neurobiology of schizophrenia

Frontiers in Neuroscience

Volumn 10, Issue MAY, 2016, Pages

  Cariaga Martinez, Ariel ^a   Saiz Ruiz, Jerónimo ^b,c   Alelú Paz, Raúl ^a,b  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

Author keywords

DNA methylation; Epigenetics; Neuroscience; Psychiatric diagnose; Schizophrenia

Indexed keywords

COGNITION; DNA SEQUENCE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIDEMIOLOGY; EPIGENETICS; GENE EXPRESSION; GENETIC LINKAGE; GENETIC RISK; HERITABILITY; HUMAN; NEUROANATOMY; NEUROBIOLOGY; NONHUMAN; PHENOTYPE; QUANTITATIVE TRAIT LOCUS; REGULATORY MECHANISM; REVIEW; SCHIZOPHRENIA; SEQUENCE HOMOLOGY;

EID: 84973525547     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2016.00202     Document Type: Review

References (222)

1. Abdolmaleky, H. M., Cheng, K. H., Faraone, S. V., Wilcox, M., Glatt, S. J., Gao, F., et al. (2006). Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum. Mol. Genet. 15, 3132-3145. doi: 10.1093/hmg/ddl253
2. Abdolmaleky, H. M., Cheng, K. H., Russo, A., Smith, C. L., Faraone, S. V., Wilcox, M., et al. (2005). Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am. J. Med. Genet. B Neuropsychiatr. Genet. 134B, 60-66. doi: 10.1002/ajmg.b.30140
3. Abdolmaleky, H. M., Nohesara, S., Ghadirivasfi, M., Lambert, A. W., Ahmadkhaniha, H., Ozturk, S., et al. (2014). DNA hypermethylation of serotonin transporter gene promoter in drug naive patients with schizophrenia. Schizophr. Res. 152, 373-380. doi: 10.1016/j.schres.2013.12.007
4. Abdolmaleky, H. M., Pajouhanfar, S., Faghankhani, M., Joghataei, M. T., Mostafavi, A., and Thiagalingam, S. (2015). Antipsychotic drugs attenuate aberrant DNA methylation of DTNBP1 (dysbindin) promoter in saliva and post-mortem brain of patients with schizophrenia and Psychotic bipolar disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 168, 687-696. doi: 10.1002/ajmg.b.32361
5. Abdolmaleky, H. M., Yaqubi, S., Papageorgis, P., Lambert, A. W., Ozturk, S., Sivaraman, V., et al. (2011). Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder. Schizophr. Res. 129, 183-190. doi: 10.1016/j.schres.2011.04.007
6. Agerbo, E., Sullivan, P. F., Vilhjalmsson, B. J., Pedersen, C. B., Mors, O., Borglum, A. D., et al. (2015). Polygenic risk score, parental socioeconomic status, family history of psychiatric disorders, and the risk for schizophrenia: a danish population-based study and meta-analysis. JAMA Psychiatry 72, 635-641. doi: 10.1001/jamapsychiatry.2015.0346
7. Akbarian, S. (2010). Epigenetics of schizophrenia. Curr. Top. Behav. Neurosci. 4, 611-628. doi: 10.1007/7854_2010_38
8. Akbarian, S., Ruehl, M. G., Bliven, E., Luiz, L. A., Peranelli, A. C., Baker, S. P., et al. (2005). Chromatin alterations associated with down-regulated metabolic gene expression in the prefrontal cortex of subjects with schizophrenia. Arch. Gen. Psychiatry 62, 829-840. doi: 10.1001/archpsyc.62.8.829
9. Allen, A. J., Griss, M. E., Folley, B. S., Hawkins, K. A., and Pearlson, G. D. (2009). Endophenotypes in schizophrenia: a selective review. Schizophr. Res. 109, 24-37. doi: 10.1016/j.schres.2009.01.016
10. Allen, N. C., Bagade, S., McQueen, M. B., Ioannidis, J. P., Kavvoura, F. K., Khoury, M. J., et al. (2008). Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat. Genet. 40, 827-834. doi: 10.1038/ng.171
11. Almasy, L., Gur, R. C., Haack, K., Cole, S. A., Calkins, M. E., Peralta, J. M., et al. (2008). A genome screen for quantitative trait loci influencing schizophrenia and neurocognitive phenotypes. Am. J. Psychiatry 165, 1185-1192. doi: 10.1176/appi.ajp.2008.07121869
12. Andreasen, N. C., Ehrhardt, J. C., Swayze, V. W. II, Alliger, R. J., Yuh, W. T., Cohen, G., et al. (1990). Magnetic resonance imaging of the brain in schizophrenia. The pathophysiologic significance of structural abnormalities. Arch. Gen. Psychiatry 47, 35-44. doi: 10.1001/archpsyc.1990.01810130037006
13. Andreasen, N. C., Olsen, S. A., Dennert, J. W., and Smith, M. R. (1982). Ventricular enlargement in schizophrenia: relationship to positive and negative symptoms. Am. J. Psychiatry 139, 297-302. doi: 10.1176/ajp.139.3.297
14. Andreassen, O. A., Harbo, H. F., Wang, Y., Thompson, W. K., Schork, A. J., Mattingsdal, M., et al. (2015). Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci. Mol. Psychiatry 20, 207-214. doi: 10.1038/mp.2013.195
15. Arciniegas, D., Rojas, D. C., Teale, P., Sheeder, J., Sandberg, E., and Reite, M. (1999). The thalamus and the schizophrenia phenotype: failure to replicate reduced volume. Biol. Psychiatry 45, 1329-1335. doi: 10.1016/S0006-3223(97)00459-9
16. Arnold, S. J., Ivleva, E. I., Gopal, T. A., Reddy, A. P., Jeon-Slaughter, H., Sacco, C. B., et al. (2015). Hippocampal volume is reduced in schizophrenia and schizoaffective disorder but not in psychotic bipolar I disorder demonstrated by both manual tracing and automated parcellation (FreeSurfer). Schizophr. Bull. 41, 233-249. doi: 10.1093/schbul/sbu009
17. Arnone, D., Cavanagh, J., Gerber, D., Lawrie, S. M., Ebmeier, K. P., and McIntosh, A. M. (2009). Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis. Br. J. Psychiatry 195, 194-201. doi: 10.1192/bjp.bp.108.059717
18. Athanasiu, L., Mattingsdal, M., Kahler, A. K., Brown, A., Gustafsson, O., Agartz, I., et al. (2010). Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort. J. Psychiatr. Res. 44, 748-753. doi: 10.1016/j.jpsychires.2010.02.002
19. Badano, J. L., and Katsanis, N. (2002). Beyond Mendel: an evolving view of human genetic disease transmission. Nat. Rev. Genet. 3, 779-789. doi: 10.1038/nrg910
20. Bearden, C. E., and Freimer, N. B. (2006). Endophenotypes for psychiatric disorders: ready for primetime? Trends Genet. 22, 306-313. doi: 10.1016/j.tig.2006.04.004
21. Bharadwaj, R., Jiang, Y., Mao, W., Jakovcevski, M., Dincer, A., Krueger, W., et al. (2013). Conserved chromosome 2q31 conformations are associated with transcriptional regulation of GAD1 GABA synthesis enzyme and altered in prefrontal cortex of subjects with schizophrenia. J. Neurosci. 33, 11839-11851. doi: 10.1523/JNEUROSCI.1252-13.2013
22. Bollati, V., Baccarelli, A., Hou, L., Bonzini, M., Fustinoni, S., Cavallo, D., et al. (2007). Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res. 67, 876-880. doi: 10.1158/0008-5472.CAN-06-2995
23. Braff, D. L. (2015). The importance of endophenotypes in schizophrenia research. Schizophr. Res. 163, 1-8. doi: 10.1016/j.schres.2015.02.007
24. Braff, D. L., Greenwood, T. A., Swerdlow, N. R., Light, G. A., and Schork, N. J. (2008). Advances in endophenotyping schizophrenia. World Psychiatry 7, 11-18. doi: 10.1002/j.2051-5545.2008.tb00140.x
25. Braff, D. L., and Light, G. A. (2005). The use of neurophysiological endophenotypes to understand the genetic basis of schizophrenia. Dialogues Clin. Neurosci. 7, 125-135.
26. Bukovskaya, O., and Shmukler, A. (2015). Oxytocin and social cognitions in schizophrenia: a systematic review. Psychiatr. Q. doi: 10.1007/s11126-015-9407-x. [Epub ahead of print].
27. Byne, W., Buchsbaum, M. S., Mattiace, L. A., Hazlett, E. A., Kemether, E., Elhakem, S. L., et al. (2002). Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. Am. J. Psychiatry 159, 59-65. doi: 10.1176/appi.ajp.159.1.59
28. Calhoun, V. D., Eichele, T., and Pearlson, G. (2009). Functional brain networks in schizophrenia: a review. Front. Hum. Neurosci. 3:17. doi: 10.3389/neuro.09.017.2009
29. Carrard, A., Salzmann, A., Malafosse, A., and Karege, F. (2011). Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder. J. Affect. Disord. 132, 450-453. doi: 10.1016/j.jad.2011.03.018
30. Castellani, C. A., Melka, M. G., Gui, J. L., O'Reilly, R. L., and Singh, S. M. (2015). Integration of DNA sequence and DNA methylation changes in monozygotic twin pairs discordant for schizophrenia. Schizophr. Res. 169, 433-440. doi: 10.1016/j.schres.2015.09.021
31. Chase, K. A., Gavin, D. P., Guidotti, A., and Sharma, R. P. (2013). Histone methylation at H3K9: evidence for a restrictive epigenome in schizophrenia. Schizophr. Res. 149, 15-20. doi: 10.1016/j.schres.2013.06.021
32. Chen, C., Zhang, C., Cheng, L., Reilly, J. L., Bishop, J. R., Sweeney, J. A., et al. (2014). Correlation between DNA methylation and gene expression in the brains of patients with bipolar disorder and schizophrenia. Bipolar Disord. 16, 790-799. doi: 10.1111/bdi.12255
33. Chen, X., Lee, G., Maher, B. S., Fanous, A. H., Chen, J., Zhao, Z., et al. (2011). GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia. Mol. Psychiatry 16, 1117-1129. doi: 10.1038/mp.2010.96
34. Chen, X., Wang, X., O'Neill, A. F., Walsh, D., and Kendler, K. S. (2004). Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families. Mol. Psychiatry 9, 962-967. doi: 10.1038/sj.mp.4001519
35. Cheng, M. C., Liao, D. L., Hsiung, C. A., Chen, C. Y., Liao, Y. C., and Chen, C. H. (2008). Chronic treatment with aripiprazole induces differential gene expression in the rat frontal cortex. Int. J. Neuropsychopharmacol. 11, 207-216. doi: 10.1017/s1461145707008048
36. Chowdari, K. V., Mirnics, K., Semwal, P., Wood, J., Lawrence, E., Bhatia, T., et al. (2002). Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum. Mol. Genet. 11, 1373-1380. doi: 10.1093/hmg/11.12.1373
37. Cross-Disorder Group of the Psychiatric Genomics Consortium (2013). Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381, 1371-1379. doi: 10.1016/S0140-6736(12)62129-1
38. Cuthbert, B. N., and Insel, T. R. (2013). Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med. 11:126. doi: 10.1186/1741-7015-11-126
39. Davies, M. N., Volta, M., Pidsley, R., Lunnon, K., Dixit, A., Lovestone, S., et al. (2012). Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol. 13:R43. doi: 10.1186/gb-2012-13-6-r43
40. Davis, K. L., Buchsbaum, M. S., Shihabuddin, L., Spiegel-Cohen, J., Metzger, M., Frecska, E., et al. (1998). Ventricular enlargement in poor-outcome schizophrenia. Biol. Psychiatry 43, 783-793. doi: 10.1016/S0006-3223(97)00553-2
41. Dean, D. J., Orr, J. M., Bernard, J. A., Gupta, T., Pelletier-Baldelli, A., Carol, E. E., et al. (2016). Hippocampal shape abnormalities predict symptom progression in neuroleptic-free youth at ultrahigh risk for psychosis. Schizophr. Bull. 42, 161-169. doi: 10.1093/schbul/sbv086
42. DeLisi, E. I., Schwartz, C. C., Targum, S. D., Byrnes, S. M., Spoor, E. C., Weinberger, D. R., et al. (1983). Ventricular brain enlargement and outcome of acute schizophreniform disorder. Psychiatry Res. 9, 169-171. doi: 10.1016/0165-1781(83)90038-0
43. Dempster, E. L., Pidsley, R., Schalkwyk, L. C., Owens, S., Georgiades, A., Kane, F., et al. (2011). Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum. Mol. Genet. 20, 4786-4796. doi: 10.1093/hmg/ddr416
44. De Peri, L., Crescini, A., Deste, G., Fusar-Poli, P., Sacchetti, E., and Vita, A. (2012). Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies. Curr. Pharm. Des. 18, 486-494. doi: 10.2174/138161212799316253
45. Desaulniers, D., Xiao, G. H., Leingartner, K., Chu, I., Musicki, B., and Tsang, B. K. (2005). Comparisons of brain, uterus, and liver mRNA expression for cytochrome p450s, DNA methyltransferase-1, and catechol-o-methyltransferase in prepubertal female Sprague-Dawley rats exposed to a mixture of aryl hydrocarbon receptor agonists. Toxicol. Sci. 86, 175-184. doi: 10.1093/toxsci/kfi178
46. Dong, E., Nelson, M., Grayson, D. R., Costa, E., and Guidotti, A. (2008). Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation. Proc. Natl. Acad. Sci. U.S.A. 105, 13614-13619. doi: 10.1073/pnas.0805493105
47. Dudbridge, F. (2013). Power and predictive accuracy of polygenic risk scores. PLoS Genet. 9:e1003348. doi: 10.1371/annotation/b91ba224-10be-409d-93f4-7423d502cba0
48. Edwards, A. C., Bigdeli, T. B., Docherty, A. R., Bacanu, S., Lee, D., de Candia, T. R., et al. (2015). Meta-analysis of positive and negative symptoms reveals schizophrenia modifier genes. Schizophr. Bull. 42, 279-287. doi: 10.1093/schbul/sbv119
49. Escamilla, M., Hare, E., Dassori, A. M., Peralta, J. M., Ontiveros, A., Nicolini, H., et al. (2009). A schizophrenia gene locus on chromosome 17q21 in a new set of families of Mexican and central american ancestry: evidence from the NIMH Genetics of schizophrenia in latino populations study. Am. J. Psychiatry 166, 442-449. doi: 10.1176/appi.ajp.2008.08040612
50. Farber, N. B. (2003). The NMDA receptor hypofunction model of psychosis. Ann. N. Y. Acad. Sci. 1003, 119-130. doi: 10.1196/annals.1300.008
51. Feng, J., Zhou, Y., Campbell, S. L., Le, T., Li, E., Sweatt, J. D., et al. (2010). Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat. Neurosci. 13, 423-430. doi: 10.1038/nn.2514
52. Fnu, S., Williamson, E. A., De Haro, L. P., Brenneman, M., Wray, J., Shaheen, M., et al. (2011). Methylation of histone H3 lysine 36 enhances DNA repair by nonhomologous end-joining. Proc. Natl. Acad. Sci. U.S.A. 108, 540-545. doi: 10.1073/pnas.1013571108
53. Gaser, C., Nenadic, I., Buchsbaum, B. R., Hazlett, E. A., and Buchsbaum, M. S. (2004). Ventricular enlargement in schizophrenia related to volume reduction of the thalamus, striatum, and superior temporal cortex. Am. J. Psychiatry 161, 154-156. doi: 10.1176/appi.ajp.161.1.154
54. Gejman, P. V., Sanders, A. R., and Duan, J. (2010). The role of genetics in the etiology of schizophrenia. Psychiatr. Clin. North Am. 33, 35-66. doi: 10.1016/j.psc.2009.12.003
55. Ghadirivasfi, M., Nohesara, S., Ahmadkhaniha, H. R., Eskandari, M. R., Mostafavi, S., Thiagalingam, S., et al. (2011). Hypomethylation of the serotonin receptor type-2A Gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 156B, 536-545. doi: 10.1002/ajmg.b.31192
56. Gilad, Y., Rifkin, S. A., and Pritchard, J. K. (2008). Revealing the architecture of gene regulation: the promise of eQTL studies. Trends Genet. 24, 408-415. doi: 10.1016/j.tig.2008.06.001
57. Girard, S. L., Gauthier, J., Noreau, A., Xiong, L., Zhou, S., Jouan, L., et al. (2011). Increased exonic de novo mutation rate in individuals with schizophrenia. Nat. Genet. 43, 860-863. doi: 10.1038/ng.886
58. Glahn, D. C., Knowles, E. E., McKay, D. R., Sprooten, E., Raventos, H., Blangero, J., et al. (2014). Arguments for the sake of endophenotypes: examining common misconceptions about the use of endophenotypes in psychiatric genetics. Am. J. Med. Genet. B Neuropsychiatr. Genet. 165B, 122-130. doi: 10.1002/ajmg.b.32221
59. Glatt, S. J., Stone, W. S., Nossova, N., Liew, C. C., Seidman, L. J., and Tsuang, M. T. (2011). Similarities and differences in peripheral blood gene-expression signatures of individuals with schizophrenia and their first-degree biological relatives. Am. J. Med. Genet. B Neuropsychiatr. Genet. 156B, 869-887. doi: 10.1002/ajmg.b.31239
60. Glausier, J. R., Kimoto, S., Fish, K. N., and Lewis, D. A. (2015). Lower glutamic acid decarboxylase 65-kDa isoform messenger RNA and protein levels in the prefrontal cortex in schizoaffective disorder but not schizophrenia. Biol. Psychiatry 77, 167-176. doi: 10.1016/j.biopsych.2014.05.010
61. Goate, A., Chartier-Harlin, M. C., Mullan, M., Brown, J., Crawford, F., Fidani, L., et al. (1991). Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706. doi: 10.1038/349704a0
62. Gottesman, I. I., and Gould, T. D. (2003). The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 160, 636-645. doi: 10.1176/appi.ajp.160.4.636
63. Gottesman, I. I., and Shields, J. (1967). A polygenic theory of schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 58, 199-205. doi: 10.1073/pnas.58.1.199
64. Grayson, D. R., Jia, X., Chen, Y., Sharma, R. P., Mitchell, C. P., Guidotti, A., et al. (2005). Reelin promoter hypermethylation in schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 102, 9341-9346. doi: 10.1073/pnas.0503736102
65. Greenwood, T. A., Light, G. A., Swerdlow, N. R., Radant, A. D., and Braff, D. L. (2012). Association analysis of 94 candidate genes and schizophrenia-related endophenotypes. PLoS ONE 7:e29630. doi: 10.1371/journal.pone.0029630
66. Greer, E. L., and Shi, Y. (2012). Histone methylation: a dynamic mark in health, disease and inheritance. Nat. Rev. Genet. 13, 343-357. doi: 10.1038/nrg3173
67. Guan, J. S., Haggarty, S. J., Giacometti, E., Dannenberg, J. H., Joseph, N., Gao, J., et al. (2009). HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459, 55-60. doi: 10.1038/nature07925
68. Guan, Z., Giustetto, M., Lomvardas, S., Kim, J. H., Miniaci, M. C., Schwartz, J. H., et al. (2002). Integration of long-term-memory-related synaptic plasticity involves bidirectional regulation of gene expression and chromatin structure. Cell 111, 483-493. doi: 10.1016/S0092-8674(02)01074-7
69. Guidotti, A., Ruzicka, W., Grayson, D. R., Veldic, M., Pinna, G., Davis, J. M., et al. (2007). S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis. Neuroreport 18, 57-60. doi: 10.1097/WNR.0b013e32800fefd7
70. Guo, W., Hu, M., Fan, X., Liu, F., Wu, R., Chen, J., et al. (2014). Decreased gray matter volume in the left middle temporal gyrus as a candidate biomarker for schizophrenia: a study of drug naive, first-episode schizophrenia patients and unaffected siblings. Schizophr. Res. 159, 43-50. doi: 10.1016/j.schres.2014.07.051
71. Gur, R. E., Calkins, M. E., Gur, R. C., Horan, W. P., Nuechterlein, K. H., Seidman, L. J., et al. (2007). The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes. Schizophr. Bull. 33, 49-68. doi: 10.1093/schbul/sbl055
72. Gurling, H. M., Kalsi, G., Brynjolfson, J., Sigmundsson, T., Sherrington, R., Mankoo, B. S., et al. (2001). Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. Am. J. Hum. Genet. 68, 661-673. doi: 10.1086/318788
73. Hazlett, E. A., Buchsbaum, M. S., Haznedar, M. M., Newmark, R., Goldstein, K. E., Zelmanova, Y., et al. (2008). Cortical gray and white matter volume in unmedicated schizotypal and schizophrenia patients. Schizophr. Res. 101, 111-123. doi: 10.1016/j.schres.2007.12.472
74. Health, N. I. o. (2008). Policy for Sharing of Data Obtained in NIH Supported or Conducted Genome-Wide Association Studies (GWAS). Bethesda, MD: National Institute of Health.
75. Hirschhorn, J. N., and Daly, M. J. (2005). Genome-wide association studies for common diseases and complex traits. Nat. Rev. Genet. 6, 95-108. doi: 10.1038/nrg1521
76. Horga, G., Bernacer, J., Dusi, N., Entis, J., Chu, K., Hazlett, E. A., et al. (2011). Correlations between ventricular enlargement and gray and white matter volumes of cortex, thalamus, striatum, and internal capsule in schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 261, 467-476. doi: 10.1007/s00406-011-0202-x
77. Hu, M., Li, J., Eyler, L., Guo, X., Wei, Q., Tang, J., et al. (2013). Decreased left middle temporal gyrus volume in antipsychotic drug-naive, first-episode schizophrenia patients and their healthy unaffected siblings. Schizophr. Res. 144, 37-42. doi: 10.1016/j.schres.2012.12.018
78. Huang, H. S., and Akbarian, S. (2007). GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia. PLoS ONE 2:e809. doi: 10.1371/journal.pone.0000809
79. Ibi, D., and Gonzalez-Maeso, J. (2015). Epigenetic signaling in schizophrenia. Cell. Signal. 27, 2131-2136. doi: 10.1016/j.cellsig.2015.06.003
80. Iwamoto, K., Bundo, M., Ueda, J., Oldham, M. C., Ukai, W., Hashimoto, E., et al. (2011). Neurons show distinctive DNA methylation profile and higher interindividual variations compared with non-neurons. Genome Res. 21, 688-696. doi: 10.1101/gr.112755.110
81. Jack, A., Connelly, J. J., and Morris, J. P. (2012). DNA methylation of the oxytocin receptor gene predicts neural response to ambiguous social stimuli. Front. Hum. Neurosci. 6:280. doi: 10.3389/fnhum.2012.00280
82. Jaffe, A. E., Gao, Y., Deep-Soboslay, A., Tao, R., Hyde, T. M., Weinberger, D. R., et al. (2016). Mapping DNA methylation across development, genotype and schizophrenia in the human frontal cortex. Nat. Neurosci. 19, 40-47. doi: 10.1038/nn.4181
83. Jones, H. J., Stergiakouli, E., Tansey, K. E., Hubbard, L., Heron, J., Cannon, M., et al. (2016). Phenotypic manifestation of genetic risk for schizophrenia during adolescence in the general population. JAMA Psychiatry 73, 221-228. doi: 10.1001/jamapsychiatry.2015.3058
84. Kaminsky, Z. A., Tang, T., Wang, S. C., Ptak, C., Oh, G. H., Wong, A. H., et al. (2009). DNA methylation profiles in monozygotic and dizygotic twins. Nat. Genet. 41, 240-245. doi: 10.1038/ng.286
85. Kendler, K. S. (2016). The schizophrenia polygenic risk score: to what does it predispose in adolescence? JAMA Psychiatry 73, 193-194. doi: 10.1001/jamapsychiatry.2015.2964
86. Kinoshita, M., Numata, S., Tajima, A., Ohi, K., Hashimoto, R., Shimodera, S., et al. (2014). Aberrant DNA methylation of blood in schizophrenia by adjusting for estimated cellular proportions. Neuromolecular Med. 16, 697-703. doi: 10.1007/s12017-014-8319-5
87. Kinoshita, M., Numata, S., Tajima, A., Shimodera, S., Ono, S., Imamura, A., et al. (2013). DNA methylation signatures of peripheral leukocytes in schizophrenia. Neuromolecular Med. 15, 95-101. doi: 10.1007/s12017-012-8198-6
88. Kirov, G., Zaharieva, I., Georgieva, L., Moskvina, V., Nikolov, I., Cichon, S., et al. (2009). A genome-wide association study in 574 schizophrenia trios using DNA pooling. Mol. Psychiatry 14, 796-803. doi: 10.1038/mp.2008.33
89. Konick, L. C., and Friedman, L. (2001). Meta-analysis of thalamic size in schizophrenia. Biol. Psychiatry 49, 28-38. doi: 10.1016/S0006-3223(00)00974-4
90. Korzus, E., Rosenfeld, M. G., and Mayford, M. (2004). CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron 42, 961-972. doi: 10.1016/j.neuron.2004.06.002
91. Kozlenkov, A., Roussos, P., Timashpolsky, A., Barbu, M., Rudchenko, S., Bibikova, M., et al. (2014). Differences in DNA methylation between human neuronal and glial cells are concentrated in enhancers and non-CpG sites. Nucleic Acids Res. 42, 109-127. doi: 10.1093/nar/gkt838
92. Kumsta, R., Hummel, E., Chen, F. S., and Heinrichs, M. (2013). Epigenetic regulation of the oxytocin receptor gene: implications for behavioral neuroscience. Front. Neurosci. 7:83. doi: 10.3389/fnins.2013.00083
93. Kurita, M., Holloway, T., Garcia-Bea, A., Kozlenkov, A., Friedman, A. K., Moreno, J. L., et al. (2012). HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity. Nat. Neurosci. 15, 1245-1254. doi: 10.1038/nn.3181
94. Labrie, V., Pai, S., and Petronis, A. (2012). Epigenetics of major psychosis: progress, problems and perspectives. Trends Genet. 28, 427-435. doi: 10.1016/j.tig.2012.04.002
95. Ladd-Acosta, C., Pevsner, J., Sabunciyan, S., Yolken, R. H., Webster, M. J., Dinkins, T., et al. (2007). DNA methylation signatures within the human brain. Am. J. Hum. Genet. 81, 1304-1315. doi: 10.1086/524110
96. Laird, P. W. (2010). Principles and challenges of genomewide DNA methylation analysis. Nat. Rev. Genet. 11, 191-203. doi: 10.1038/nrg2732
97. Lee, K. W., Woon, P. S., Teo, Y. Y., and Sim, K. (2012). Genome wide association studies (GWAS) and copy number variation (CNV) studies of the major psychoses: what have we learnt? Neurosci. Biobehav. Rev. 36, 556-571. doi: 10.1016/j.neubiorev.2011.09.001
98. Lencer, R., Sprenger, A., Reilly, J. L., McDowell, J. E., Rubin, L. H., Badner, J. A., et al. (2015). Pursuit eye movements as an intermediate phenotype across psychotic disorders: evidence from the B-SNIP study. Schizophr. Res. 169, 326-333. doi: 10.1016/j.schres.2015.09.032
99. Lencz, T., Morgan, T. V., Athanasiou, M., Dain, B., Reed, C. R., Kane, J. M., et al. (2007). Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia. Mol. Psychiatry 12, 572-580. doi: 10.1038/sj.mp.4001983
100. Lerer, B., Segman, R. H., Hamdan, A., Kanyas, K., Karni, O., Kohn, Y., et al. (2003). Genome scan of Arab Israeli families maps a schizophrenia susceptibility gene to chromosome 6q23 and supports a locus at chromosome 10q24. Mol. Psychiatry 8, 488-498. doi: 10.1038/sj.mp.4001322
101. Lesch, A., and Bogerts, B. (1984). The diencephalon in schizophrenia: evidence for reduced thickness of the periventricular grey matter. Eur. Arch. Psychiatry Neurol. Sci. 234, 212-219. doi: 10.1007/BF00381351
102. Levenson, J. M., Roth, T. L., Lubin, F. D., Miller, C. A., Huang, I. C., Desai, P., et al. (2006). Evidence that DNA (cytosine-5) methyltransferase regulates synaptic plasticity in the hippocampus. J. Biol. Chem. 281, 15763-15773. doi: 10.1074/jbc. M511767200
103. Light, G., Greenwood, T. A., Swerdlow, N. R., Calkins, M. E., Freedman, R., Green, M. F., et al. (2014). Comparison of the heritability of schizophrenia and endophenotypes in the COGS-1 family study. Schizophr. Bull. 40, 1404-1411. doi: 10.1093/schbul/sbu064
104. Lindholm, E., Ekholm, B., Shaw, S., Jalonen, P., Johansson, G., Pettersson, U., et al. (2001). A schizophrenia-susceptibility locus at 6q25, in one of the world's largest reported pedigrees. Am. J. Hum. Genet. 69, 96-105. doi: 10.1086/321288
105. Liou, Y. J., Wang, H. H., Lee, M. T., Wang, S. C., Chiang, H. L., Chen, C. C., et al. (2012). Genome-wide association study of treatment refractory schizophrenia in han chinese. PLoS ONE 7:e33598. doi: 10.1371/journal.pone.0033598
106. Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., et al. (2008). Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci. 31, 234-242. doi: 10.1016/j.tins.2008.02.005
107. Liu, Y., Chen, G., Norton, N., Liu, W., Zhu, H., Zhou, P., et al. (2009). Whole genome association study in a homogenous population in Shandong peninsula of China reveals JARID2 as a susceptibility gene for schizophrenia. J. Biomed. Biotechnol. 2009:536918. doi: 10.1155/2009/536918
108. Lokk, K., Modhukur, V., Rajashekar, B., Martens, K., Magi, R., Kolde, R., et al. (2014). DNA methylome profiling of human tissues identifies global and tissue-specific methylation patterns. Genome Biol. 15:r54. doi: 10.1186/gb-2014-15-4-r54
109. Lubin, F. D., Roth, T. L., and Sweatt, J. D. (2008). Epigenetic regulation of BDNF gene transcription in the consolidation of fear memory. J. Neurosci. 28, 10576-10586. doi: 10.1523/JNEUROSCI.1786-08.2008
110. Mah, S., Nelson, M. R., Delisi, L. E., Reneland, R. H., Markward, N., James, M. R., et al. (2006). Identification of the semaphorin receptor PLXNA2 as a candidate for susceptibility to schizophrenia. Mol. Psychiatry 11, 471-478. doi: 10.1038/sj.mp.4001785
111. Maher, B. S., Reimers, M. A., Riley, B. P., and Kendler, K. S. (2010). Allelic heterogeneity in genetic association meta-analysis: an application to DTNBP1 and schizophrenia. Hum. Hered. 69, 71-79. doi: 10.1159/000264445
112. Maj, M. (2011). Understanding the pathophysiology of schizophrenia: are we on the wrong or on the right track? Schizophr. Res. 127, 20-21. doi: 10.1016/j.schres.2011.01.002
113. Mantripragada, K. K., Carroll, L. S., and Williams, N. M. (2010). Experimental approaches for identifying schizophrenia risk genes. Curr. Top. Behav. Neurosci. 4, 587-610. doi: 10.1007/7854_2010_58
114. Marcelis, M., Suckling, J., Woodruff, P., Hofman, P., Bullmore, E., and van Os, J. (2003). Searching for a structural endophenotype in psychosis using computational morphometry. Psychiatry Res. 122, 153-167. doi: 10.1016/S0925-4927(02)00125-7
115. Maric, N. P., and Svrakic, D. M. (2012). Why schizophrenia genetics needs epigenetics: a review. Psychiatr. Danub. 24, 2-18.
116. Maunakea, A. K., Nagarajan, R. P., Bilenky, M., Ballinger, T. J., D'Souza, C., Fouse, S. D., et al. (2010). Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 466, 253-257. doi: 10.1038/nature09165
117. Melkonian, S. C., Daniel, C. R., Ye, Y., Tannir, N. M., Karam, J. A., Matin, S. F., et al. (2015). Gene-environment interaction of genome-wide association study-identified susceptibility loci and meat-cooking mutagens in the etiology of renal cell carcinoma. Cancer 122, 108-115. doi: 10.1158/1538-7445.am2015-836
118. Michaelson, J. J., Loguercio, S., and Beyer, A. (2009). Detection and interpretation of expression quantitative trait loci (eQTL). Methods 48, 265-276. doi: 10.1016/j.ymeth.2009.03.004
119. Mileaf, M. I., and Byne, W. (2012). Neuronal deficit in medial pulvinar from right but not left hemisphere in schizophrenia. Schizophr. Res. 134, 291-292. doi: 10.1016/j.schres.2011.10.012
120. Mill, J., Tang, T., Kaminsky, Z., Khare, T., Yazdanpanah, S., Bouchard, L., et al. (2008). Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am. J. Hum. Genet. 82, 696-711. doi: 10.1016/j.ajhg.2008.01.008
121. Molina-Serrano, D., and Kirmizis, A. (2013). Beyond the histone tail: acetylation at the nucleosome dyad commands transcription. Nucleus 4, 343-348. doi: 10.4161/nucl.26051
122. Mor, M., Nardone, S., Sams, D. S., and Elliott, E. (2015). Hypomethylation of miR-142 promoter and upregulation of microRNAs that target the oxytocin receptor gene in the autism prefrontal cortex. Mol. Autism 6:46. doi: 10.1186/s13229-015-0040-1
123. Mouchlianitis, E., Bloomfield, M. A., Law, V., Beck, K., Selvaraj, S., Rasquinha, N., et al. (2015). Treatment-resistant schizophrenia patients show elevated anterior cingulate cortex glutamate compared to treatment-responsive. Schizophr. Bull. 42, 744-752. doi: 10.1093/schbul/sbv151
124. Munafo, M. R., Attwood, A. S., and Flint, J. (2008). Neuregulin 1 genotype and schizophrenia. Schizophr. Bull. 34, 9-12. doi: 10.1093/schbul/sbm129
125. Nasrallah, H. A., Jacoby, C. G., McCalley-Whitters, M., and Kuperman, S. (1982). Cerebral ventricular enlargement in subtypes of chronic schizophrenia. Arch. Gen. Psychiatry 39, 774-777. doi: 10.1001/archpsyc.1982.04290070010003
126. Nasrallah, H. A., Olson, S. C., McCalley-Whitters, M., Chapman, S., and Jacoby, C. G. (1986). Cerebral ventricular enlargement in schizophrenia. A preliminary follow-up study. Arch. Gen. Psychiatry 43, 157-159. doi: 10.1001/archpsyc.1986.01800020067008
127. Need, A. C., Ge, D., Weale, M. E., Maia, J., Feng, S., Heinzen, E. L., et al. (2009). A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet. 5:e1000373. doi: 10.1371/annotation/e0196ebb-de40-453f-8f8c-791b126618da
128. Nishioka, M., Bundo, M., Koike, S., Takizawa, R., Kakiuchi, C., Araki, T., et al. (2013). Comprehensive DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia. J. Hum. Genet. 58, 91-97. doi: 10.1038/jhg.2012.140
129. Nohesara, S., Ghadirivasfi, M., Mostafavi, S., Eskandari, M. R., Ahmadkhaniha, H., Thiagalingam, S., et al. (2011). DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder. J. Psychiatr. Res. 45, 1432-1438. doi: 10.1016/j.jpsychires.2011.06.013
130. Obiols Llandrich, J. E., Ruscalleda, J., and Masferrer, M. (1986). Ventricular enlargement in young chronic schizophrenics. Acta Psychiatr. Scand. 73, 42-44. doi: 10.1111/j.1600-0447.1986.tb02664.x
131. O'Donovan, M. C., Craddock, N., Norton, N., Williams, H., Peirce, T., Moskvina, V., et al. (2008). Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat. Genet. 40, 1053-1055. doi: 10.1038/ng.201
132. O'Dushlaine, C., Kenny, E., Heron, E., Donohoe, G., Gill, M., Morris, D., et al. (2011). Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol. Psychiatry 16, 286-292. doi: 10.1038/mp.2010.7
133. Oliveira, A. M., Wood, M. A., McDonough, C. B., and Abel, T. (2007). Transgenic mice expressing an inhibitory truncated form of p300 exhibit long-term memory deficits. Learn. Mem. 14, 564-572. doi: 10.1101/lm.656907
134. Park, J. A., Kim, A. J., Kang, Y., Jung, Y. J., Kim, H. K., and Kim, K. C. (2011). Deacetylation and methylation at histone H3 lysine 9 (H3K9) coordinate chromosome condensation during cell cycle progression. Mol. Cells 31, 343-349. doi: 10.1007/s10059-011-0044-4
135. Pearson, T. A., and Manolio, T. A. (2008). How to interpret a genome-wide association study. JAMA 299, 1335-1344. doi: 10.1001/jama.299.11.1335
136. Pennisi, E. (2012). Genomics. ENCODE project writes eulogy for junk DNA. Science 337, 1159, 1161. doi: 10.1126/science.337.6099.1159
137. Petruk, S., Sedkov, Y., Johnston, D. M., Hodgson, J. W., Black, K. L., Kovermann, S. K., et al. (2012). TrxG and PcG proteins but not methylated histones remain associated with DNA through replication. Cell 150, 922-933. doi: 10.1016/j.cell.2012.06.046
138. Pidsley, R., Viana, J., Hannon, E., Spiers, H., Troakes, C., Al-Saraj, S., et al. (2014). Methylomic profiling of human brain tissue supports a neurodevelopmental origin for schizophrenia. Genome Biol. 15:483. doi: 10.1186/s13059-014-0483-2
139. Pletnikov, M. V., Ayhan, Y., Nikolskaia, O., Xu, Y., Ovanesov, M. V., Huang, H., et al. (2008). Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol. Psychiatry 13, 173-186, 115. doi: 10.1038/sj.mp.4002079
140. Portela, A., and Esteller, M. (2010). Epigenetic modifications and human disease. Nat. Biotechnol. 28, 1057-1068. doi: 10.1038/nbt.1685
141. Puglia, M. H., Lillard, T. S., Morris, J. P., and Connelly, J. J. (2015). Epigenetic modification of the oxytocin receptor gene influences the perception of anger and fear in the human brain. Proc. Natl. Acad. Sci. U.S.A. 112, 3308-3313. doi: 10.1073/pnas.1422096112
142. Purcell, S. M., Wray, N. R., Stone, J. L., Visscher, P. M., O'Donovan, M. C., Sullivan, P. F., et al. (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748-752. doi: 10.1038/nature08185
143. Rajasethupathy, P., Antonov, I., Sheridan, R., Frey, S., Sander, C., Tuschl, T., et al. (2012). A Role for Neuronal piRNAs in the epigenetic control of memory-related synaptic plasticity. Cell 149, 693-707. doi: 10.1016/j.cell.2012.02.057
144. Rampon, C., Jiang, C. H., Dong, H., Tang, Y. P., Lockhart, D. J., Schultz, P. G., et al. (2000). Effects of environmental enrichment on gene expression in the brain. Proc. Natl. Acad. Sci. U.S.A. 97, 12880-12884. doi: 10.1073/pnas.97.23.12880
145. Rees, E., Kirov, G., Walters, J. T., Richards, A. L., Howrigan, D., Kavanagh, D. H., et al. (2015). Analysis of exome sequence in 604 trios for recessive genotypes in schizophrenia. Transl. Psychiatry 5:e607. doi: 10.1038/tp.2015.99
146. Reilly, J. L., Frankovich, K., Hill, S., Gershon, E. S., Keefe, R. S., Keshavan, M. S., et al. (2014). Elevated antisaccade error rate as an intermediate phenotype for psychosis across diagnostic categories. Schizophr. Bull. 40, 1011-1021. doi: 10.1093/schbul/sbt132
147. Reveley, A. M., Reveley, M. A., and Murray, R. M. (1984). Cerebral ventricular enlargement in non-genetic schizophrenia: a controlled twin study. Br. J. Psychiatry 144, 89-93. doi: 10.1192/bjp.144.1.89
148. Rietschel, M., Mattheisen, M., Degenhardt, F., Genetic Risk Outcome in Psychosis (GROUP Investigators), Mühleisen, T. W., Kirsch, P., et al. (2012). Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe. Mol. Psychiatry 17, 906-917. doi: 10.1038/mp.2011.80
149. Riley, B. (2004). Linkage studies of schizophrenia. Neurotox. Res. 6, 17-34. doi: 10.1007/BF03033293
150. Ripke, S., O'Dushlaine, C., Chambert, K., Moran, J. L., Kahler, A. K., Akterin, S., et al. (2013). Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat. Genet. 45, 1150-1159. doi: 10.1038/ng.2742
151. Ripke, S., Sanders, A. R., Kendler, K. S., Levinson, D. F., Sklar, P., Holmans, P. A., et al. (2011). Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 43, 969-976. doi: 10.1038/ng.940
152. Risch, N. (1990). Linkage strategies for genetically complex traits. I. Multilocus models. Am. J. Hum. Genet. 46, 222-228.
153. Risch, N., and Merikangas, K. (1996). The future of genetic studies of complex human diseases. Science 273, 1516-1517. doi: 10.1126/science.273.5281.1516
154. Rissling, A. J., and Light, G. A. (2010). Neurophysiological measures of sensory registration, stimulus discrimination, and selection in schizophrenia patients. Curr. Top. Behav. Neurosci. 4, 283-309. doi: 10.1007/7854_2010_59
155. Roth, E. D., Roth, T. L., Money, K. M., SenGupta, S., Eason, D. E., and Sweatt, J. D. (2015). DNA methylation regulates neurophysiological spatial representation in memory formation. Neuroepigenetics 2, 1-8. doi: 10.1016/j.nepig.2015.03.001
156. Rubin, L. H., Connelly, J. J., Reilly, J. L., Carter, C. S., Drogos, L. L., Pournajafi-Nazarloo, H., et al. (2016). Sex and diagnosis specific associations between DNA methylation of the oxytocin receptor gene with emotion processing and temporal-limbic and prefrontal brain volumes in psychotic disorders. Biol. Psychiatry Cogn. Neurosci. Neuroimaging 1, 141-151. doi: 10.1016/j.bpsc.2015.10.003
157. Ruzicka, W. B., Zhubi, A., Veldic, M., Grayson, D. R., Costa, E., and Guidotti, A. (2007). Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection. Mol. Psychiatry 12, 385-397. doi: 10.1038/sj.mp.4001954
158. Sayo, A., Jennings, R. G., and Van Horn, J. D. (2012). Study factors influencing ventricular enlargement in schizophrenia: a 20 year follow-up meta-analysis. Neuroimage 59, 154-167. doi: 10.1016/j.neuroimage.2011.07.011
159. Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium (2011). Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 43, 969-976. doi: 10.1038/ng.940
160. Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014). Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421-427. doi: 10.1038/nature13595
161. Schubeler, D. (2015). Function and information content of DNA methylation. Nature 517, 321-326. doi: 10.1038/nature14192
162. Schulz, S. C., Koller, M. M., Kishore, P. R., Hamer, R. M., Gehl, J. J., and Friedel, R. O. (1983). Ventricular enlargement in teenage patients with schizophrenia spectrum disorder. Am. J. Psychiatry 140, 1592-1595. doi: 10.1176/ajp.140.12.1592
163. Schumacher, A., Kapranov, P., Kaminsky, Z., Flanagan, J., Assadzadeh, A., Yau, P., et al. (2006). Microarray-based DNA methylation profiling: technology and applications. Nucleic Acids Res. 34, 528-542. doi: 10.1093/nar/gkj461
164. Schumacher, J., Laje, G., Abou Jamra, R., Becker, T., Muhleisen, T. W., Vasilescu, C., et al. (2009). The DISC locus and schizophrenia: evidence from an association study in a central European sample and from a meta-analysis across different European populations. Hum. Mol. Genet. 18, 2719-2727. doi: 10.1093/hmg/ddp204
165. Scoriels, L., Salek, R. M., Goodby, E., Grainger, D., Dean, A. M., West, J. A., et al. (2015). Behavioural and molecular endophenotypes in psychotic disorders reveal heritable abnormalities in glutamatergic neurotransmission. Transl. Psychiatry 5:e540. doi: 10.1038/tp.2015.26
166. Seidman, L. J., Hellemann, G., Nuechterlein, K. H., Greenwood, T. A., Braff, D. L., Cadenhead, K. S., et al. (2015). Factor structure and heritability of endophenotypes in schizophrenia: findings from the Consortium on the Genetics of Schizophrenia (COGS-1). Schizophr. Res. 163, 73-79. doi: 10.1016/j.schres.2015.01.027
167. Sekar, A., Bialas, A. R., de Rivera, H., Davis, A., Hammond, T. R., Kamitaki, N., et al. (2016). Schizophrenia risk from complex variation of complement component 4. Nature 530, 177-183. doi: 10.1038/nature16549
168. Sharma, R. P., Grayson, D. R., and Gavin, D. P. (2008). Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the National Brain Databank microarray collection. Schizophr. Res. 98, 111-117. doi: 10.1016/j.schres.2007.09.020
169. Shi, J., Gershon, E. S., and Liu, C. (2008). Genetic associations with schizophrenia: meta-analyses of 12 candidate genes. Schizophr. Res. 104, 96-107. doi: 10.1016/j.schres.2008.06.016
170. Shi, J., Levinson, D. F., Duan, J., Sanders, A. R., Zheng, Y., Pe'er, I., et al. (2009). Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460, 753-757. doi: 10.1038/nature08192
171. Shi, Y., Li, Z., Xu, Q., Wang, T., Li, T., Shen, J., et al. (2011). Common variants on 8p12 and 1q24.2 confer risk of schizophrenia. Nat. Genet. 43, 1224-1227. doi: 10.1038/ng.980
172. Shifman, S., Bronstein, M., Sternfeld, M., Pisante, A., Weizman, A., Reznik, I., et al. (2004). COMT: a common susceptibility gene in bipolar disorder and schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 128B, 61-64. doi: 10.1002/ajmg.b.30032
173. Shifman, S., Johannesson, M., Bronstein, M., Chen, S. X., Collier, D. A., Craddock, N. J., et al. (2008). Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet. 4:e28. doi: 10.1371/journal.pgen.0040028
174. Shimabukuro, M., Jinno, Y., Fuke, C., and Okazaki, Y. (2006). Haloperidol treatment induces tissue-and sex-specific changes in DNA methylation: a control study using rats. Behav. Brain Funct. 2:37. doi: 10.1186/1744-9081-2-37
175. Shipony, Z., Mukamel, Z., Cohen, N. M., Landan, G., Chomsky, E., Zeliger, S. R., et al. (2014). Dynamic and static maintenance of epigenetic memory in pluripotent and somatic cells. Nature 513, 115-119. doi: 10.1038/nature13458
176. Shorter, K. R., and Miller, B. H. (2015). Epigenetic mechanisms in schizophrenia. Prog. Biophys. Mol. Biol. 118, 1-7. doi: 10.1016/j.pbiomolbio.2015.04.008
177. Silverman, J. M., Greenberg, D. A., Altstiel, L. D., Siever, L. J., Mohs, R. C., Smith, C. J., et al. (1996). Evidence of a locus for schizophrenia and related disorders on the short arm of chromosome 5 in a large pedigree. Am. J. Med. Genet. 67, 162-171.
178. Sklar, P., Pato, M. T., Kirby, A., Petryshen, T. L., Medeiros, H., Carvalho, C., et al. (2004). Genome-wide scan in Portuguese Island families identifies 5q31-5q35 as a susceptibility locus for schizophrenia and psychosis. Mol. Psychiatry 9, 213-218. doi: 10.1038/sj.mp.4001418
179. Soh, P., Narayanan, B., Khadka, S., Calhoun, V. D., Keshavan, M. S., Tamminga, C. A., et al. (2015). Joint Coupling of Awake EEG Frequency Activity and MRI gray matter volumes in the psychosis dimension: a BSNIP study. Front. Psychiatry 6:162. doi: 10.3389/fpsyt.2015.00162
180. Staal, W. G., HulshoffPol, H. E., Schnack, H. G., Hoogendoorn, M. L., Jellema, K., and Kahn, R. S. (2000). Structural brain abnormalities in patients with schizophrenia and their healthy siblings. Am. J. Psychiatry 157, 416-421. doi: 10.1176/appi.ajp.157.3.416
181. Stefansson, H., Ophoff, R. A., Steinberg, S., Andreassen, O. A., Cichon, S., Rujescu, D., et al. (2009). Common variants conferring risk of schizophrenia. Nature 460, 744-747. doi: 10.1038/nature08186
182. Stefansson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., et al. (2002). Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71, 877-892. doi: 10.1086/342734
183. Straub, R. E., Jiang, Y., MacLean, C. J., Ma, Y., Webb, B. T., Myakishev, M. V., et al. (2002). Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am. J. Hum. Genet. 71, 337-348. doi: 10.1086/341750
184. Straub, R. E., MacLean, C. J., O'Neill, F. A., Burke, J., Murphy, B., Duke, F., et al. (1995). A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for genetic heterogeneity. Nat. Genet. 11, 287-293. doi: 10.1038/ng1195-287
185. Straub, R. E., MacLean, C. J., O'Neill, F. A., Walsh, D., and Kendler, K. S. (1997). Support for a possible schizophrenia vulnerability locus in region 5q22-31 in Irish families. Mol. Psychiatry 2, 148-155. doi: 10.1038/sj.mp.4000258
186. Sullivan, P. F. (2007). Spurious genetic associations. Biol. Psychiatry 61, 1121-1126. doi: 10.1016/j.biopsych.2006.11.010
187. Sullivan, P. F., Daly, M. J., and O'Donovan, M. (2012). Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat. Rev. Genet. 13, 537-551. doi: 10.1038/nrg3240
188. Sullivan, P. F., Lin, D., Tzeng, J. Y., van den Oord, E., Perkins, D., Stroup, T. S., et al. (2008). Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol. Psychiatry 13, 570-584. doi: 10.1038/mp.2008.25
189. Sullivan, P. 96 Psychiatric Genetics Investigators (2012). Don't give up on GWAS. Mol. Psychiatry 17, 2-3. doi: 10.1038/mp.2011.94
190. Swank, M. W., and Sweatt, J. D. (2001). Increased histone acetyltransferase and lysine acetyltransferase activity and biphasic activation of the ERK/RSK cascade in insular cortex during novel taste learning. J. Neurosci. 21, 3383-3391.
191. Takahashi, S., Glatt, S. J., Uchiyama, M., Faraone, S. V., and Tsuang, M. T. (2015). Meta-analysis of data from the Psychiatric Genomics Consortium and additional samples supports association of CACNA1C with risk for schizophrenia. Schizophr. Res. 168, 429-433. doi: 10.1016/j.schres.2015.07.033
192. Talkowski, M. E., Seltman, H., Bassett, A. S., Brzustowicz, L. M., Chen, X., Chowdari, K. V., et al. (2006). Evaluation of a susceptibility gene for schizophrenia: genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples. Biol. Psychiatry 60, 152-162. doi: 10.1016/j.biopsych.2006.02.015
193. Tandon, R., Nasrallah, H. A., and Keshavan, M. S. (2009). Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophr. Res. 110, 1-23. doi: 10.1016/j.schres.2009.03.005
194. Tesli, M., Espeseth, T., Bettella, F., Mattingsdal, M., Aas, M., Melle, I., et al. (2014). Polygenic risk score and the psychosis continuum model. Acta Psychiatr. Scand. 130, 311-317. doi: 10.1111/acps.12307
195. Tessarz, P., and Kouzarides, T. (2014). Histone core modifications regulating nucleosome structure and dynamics. Nat. Rev. Mol. Cell Biol. 15, 703-708. doi: 10.1038/nrm3890
196. Tochigi, M., Iwamoto, K., Bundo, M., Komori, A., Sasaki, T., Kato, N., et al. (2008). Methylation status of the reelin promoter region in the brain of schizophrenic patients. Biol. Psychiatry 63, 530-533. doi: 10.1016/j.biopsych.2007.07.003
197. Turetsky, B. I., Calkins, M. E., Light, G. A., Olincy, A., Radant, A. D., and Swerdlow, N. R. (2007). Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr. Bull. 33, 69-94. doi: 10.1093/schbul/sbl060
198. Urdinguio, R. G., Sanchez-Mut, J. V., and Esteller, M. (2009). Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol. 8, 1056-1072. doi: 10.1016/S1474-4422(09)70262-5
199. van Erp, T. G., Hibar, D. P., Rasmussen, J. M., Glahn, D. C., Pearlson, G. D., Andreassen, O. A., et al. (2015). Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol. Psychiatry 21:585. doi: 10.1038/mp.2015.118
200. van Os, J., Kenis, G., and Rutten, B. P. (2010). The environment and schizophrenia. Nature 468, 203-212. doi: 10.1038/nature09563
201. Velakoulis, D., Wood, S. J., Wong, M. T., McGorry, P. D., Yung, A., Phillips, L., et al. (2006). Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch. Gen. Psychiatry 63, 139-149. doi: 10.1001/archpsyc.63.2.139
202. Veldic, M., Caruncho, H. J., Liu, W. S., Davis, J., Satta, R., Grayson, D. R., et al. (2004). DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains. Proc. Natl. Acad. Sci. U.S.A. 101, 348-353. doi: 10.1073/pnas.2637013100
203. Veldic, M., Guidotti, A., Maloku, E., Davis, J. M., and Costa, E. (2005). In psychosis, cortical interneurons overexpress DNA-methyltransferase 1. Proc. Natl. Acad. Sci. U.S.A. 102, 2152-2157. doi: 10.1073/pnas.0409665102
204. Walters, K. A., Huang, Y., Azaro, M., Tobin, K., Lehner, T., Brzustowicz, L. M., et al. (2014). Meta-analysis of repository data: impact of data regularization on NIMH schizophrenia linkage results. PLoS ONE 9:e84696. doi: 10.1371/journal.pone.0084696
205. Walton, E., Hass, J., Liu, J., Roffman, J. L., Bernardoni, F., Roessner, V., et al. (2016). Correspondence of DNA methylation between blood and brain tissue and its application to schizophrenia research. Schizophr. Bull. 42, 406-414. doi: 10.1093/schbul/sbv074
206. Wang, K. S., Liu, X. F., and Aragam, N. (2010). A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder. Schizophr. Res. 124, 192-199. doi: 10.1016/j.schres.2010.09.002
207. Wang, Q., Yang, C., Gelernter, J., and Zhao, H. (2015). Pervasive pleiotropy between psychiatric disorders and immune disorders revealed by integrative analysis of multiple GWAS. Hum. Genet. 134, 1195-1209. doi: 10.1007/s00439-015-1596-8
208. Wang, W. Y., Barratt, B. J., Clayton, D. G., and Todd, J. A. (2005). Genome-wide association studies: theoretical and practical concerns. Nat. Rev. Genet. 6, 109-118. doi: 10.1038/nrg1522
209. Wang, Y., Thompson, W. K., Schork, A. J., Holland, D., Chen, C. H., Bettella, F., et al. (2016). Leveraging genomic annotations and pleiotropic enrichment for improved replication rates in schizophrenia GWAS. PLoS Genet. 12:e1005803. doi: 10.1371/journal.pgen.1005803
210. Wang, Z., Meda, S. A., Keshavan, M. S., Tamminga, C. A., Sweeney, J. A., Clementz, B. A., et al. (2015). Large-scale fusion of gray matter and resting-state functional MRI Reveals common and distinct biological markers across the psychosis spectrum in the B-SNIP cohort. Front. Psychiatry 6:174. doi: 10.3389/fpsyt.2015.00174
211. Watanabe, A., Toyota, T., Owada, Y., Hayashi, T., Iwayama, Y., Matsumata, M., et al. (2007). Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype. PLoS Biol. 5:297. doi: 10.1371/journal.pbio.0050297
212. Weaver, I. C., Cervoni, N., Champagne, F. A., D'Alessio, A. C., Sharma, S., Seckl, J. R., et al. (2004). Epigenetic programming by maternal behavior. Nat. Neurosci. 7, 847-854. doi: 10.1038/nn1276
213. Williams, H. J., Norton, N., Dwyer, S., Moskvina, V., Nikolov, I., Carroll, L., et al. (2011). Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol. Psychiatry 16, 429-441. doi: 10.1038/mp.2010.36
214. Williams, N. M., Norton, N., Williams, H., Ekholm, B., Hamshere, M. L., Lindblom, Y., et al. (2003). A systematic genomewide linkage study in 353 sib pairs with schizophrenia. Am. J. Hum. Genet. 73, 1355-1367. doi: 10.1086/380206
215. Williamson, V. S., Mamdani, M., McMichael, G. O., Kim, A. H., Lee, D., Bacanu, S., et al. (2015). Expression quantitative trait loci (eQTLs) in microRNA genes are enriched for schizophrenia and bipolar disorder association signals. Psychol. Med. 45, 2557-2569. doi: 10.1017/S0033291715000483
216. Wockner, L. F., Noble, E. P., Lawford, B. R., Young, R. M., Morris, C. P., Whitehall, V. L., et al. (2014). Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients. Transl. Psychiatry 4, e339. doi: 10.1038/tp.2013.111
217. Wright, I. C., Rabe-Hesketh, S., Woodruff, P. W., David, A. S., Murray, R. M., and Bullmore, E. T. (2000). Meta-analysis of regional brain volumes in schizophrenia. Am. J. Psychiatry 157, 16-25. doi: 10.1176/ajp.157.1.16
218. Yamada, K., Iwayama, Y., Hattori, E., Iwamoto, K., Toyota, T., Ohnishi, T., et al. (2011). Genome-wide association study of schizophrenia in Japanese population. PLoS ONE 6:e20468. doi: 10.1371/journal.pone.0020468
219. Yue, W. H., Wang, H. F., Sun, L. D., Tang, F. L., Liu, Z. H., Zhang, H. X., et al. (2011). Genome-wide association study identifies a susceptibility locus for schizophrenia in Han Chinese at 11p11.2. Nat. Genet. 43, 1228-1231. doi: 10.1038/ng.979
220. Zang, Y. F., He, Y., Zhu, C. Z., Cao, Q. J., Sui, M. Q., Liang, M., et al. (2007). Altered baseline brain activity in children with ADHD revealed by resting-state functional MRI. Brain Dev. 29, 83-91. doi: 10.1016/j.braindev.2006.07.002
221. Zhou, Y., Lu, Y., and Tian, W. (2012). Epigenetic features are significantly associated with alternative splicing. BMC Genomics 13:123. doi: 10.1186/1471-2164-13-123
222. Zhubi, A., Veldic, M., Puri, N. V., Kadriu, B., Caruncho, H., Loza, I., et al. (2009). An upregulation of DNA-methyltransferase 1 and 3a expressed in telencephalic GABAergic neurons of schizophrenia patients is also detected in peripheral blood lymphocytes. Schizophr. Res. 111, 115-122. doi: 10.1016/j.schres.2009.03.020